SEARCH

SEARCH BY CITATION

References

  • 1
    Krishnagiri C, Ajanahalli RR, Kashyap S, et al. Abnormal granulation of blood granulocytes in mucopolysaccharidosis VI-a case report. Ann Diagn Pathol 2013;17:137139.
  • 2
    Wood T, Bodamer OA, Burin MG, et al. Expert recommendations for the laboratory diagnosis of MPS VI. Mol Genet Metab 2012;106:7382.
  • 3
    Valayannopoulos V, Nicely H, Harmatz P, et al. Mucopolysaccharidosis VI. Orphanet J Rare Dis 2010;12:5.
  • 4
    Brooks DA, Gibson GJ, Karageorgos L, et al. An index case for the attenuated end of the mucopolysaccharidosis type VI clinical spectrum. Mol Genet Metab 2005;85:236238.
  • 5
    Braunlin E, Rosenfeld H, Kampmann C, et al. MPS VI Study Group. Enzyme replacement therapy for mucopolysaccharidosis VI: Long-term cardiac effects of galsulfase (Naglazyme®) therapy. J Inherit Metab Dis. 2012; [Epub ahead of print].